Skip to main content

OTC Pediatric Healthcare Market Portrays High-End Demand across Major Geographies during 2017-2022


Fact.MR has published a new research report on global OTC pediatric healthcare market Sizes, Upcoming Industry Trends, Growth Opportunity through 2018-2028 to its online database that tries to unveil the various scenarios prevailing in the OTC pediatric healthcare market. This assessment delivers a smart compilation of primary and secondary data which provides a clear insight about the future plans expected to impact the OTC pediatric healthcare market. This study comprises of prominent data which makes it a beneficial source for investors, analysts and industry experts to acquire necessary knowledge associated to the fundamental market trends, opportunities and growth drivers during the stated forecast by 2028.
Over-The-Counter (OTC) medicines can be purchased without doctor’s prescription. OTC drugs are used to treat minor ailments and are usually consumed on basis of self-diagnosis. These drugs are available at pharmacies, small convenience stores as well as at supermarkets. OTC medication is usually not recommended, especially in case of children as they are more likely to have adverse drug reactions than adults. The adverse effects wrong medicine or overdosage can result in an allergic reaction and other side-effects. OTC medicines have a low risk if used properly by adults, but these drugs pose greater risks for children, especially in the case of first-time medication or if a child is suffering from some other health conditions. According to the U.S. Food and Drug Administration (FDA), OTC medicines to treat cold and cough for children under 2 years of age should be avoided as these medicines can cause serious or life-threatening side-effects. FDA also warns against the use of codeine products to treat cold and cough in children less than 12 years of age as it can result in serious breathing problems. OTC medicines including aspirin are also not recommended for children as aspirin can lead to Reye’s syndrome in children, which is a rear but potentially serious illness.
According to the latest report by Fact.MR, the global market for OTC pediatric healthcare is anticipated to reach close to US$ 10,000 million revenue by 2022 end. The market is expected to experience sluggish growth during the forecast period, 2017 to 2022. Increasing risk of serious side-effects due to OTC medicines based on self-care decision is restricting the parents from choosing OTC drugs for children, thus leading to the decline in OTC pediatric healthcare.
OTC pediatric medicines that fall under dermatology are projected to remain top-selling products in the global OTC pediatric healthcare market between 2017 and 2022. Sale of Dermatology OTC pediatric drugs is expected to bring in nearly US$ 3,500 million revenues towards the end of 2022. Meanwhile, ENT OTC pediatric medicines are anticipated to account for lowest revenue shares. OTC cold and cough medicines are not recommended for children because of the risk of serious side-effects and high chances of developing breathing problems.
High Sales through Drug Stores/ Pharmacies
Accounting for nearly one-third of revenue share in the OTC pediatric healthcare, drug stores/ Pharmacies emerge as one of the most lucrative sales channels. Towards the end of 2022, drug stores/ pharmacies are projected to reach close to US$ 3,200 million revenues. Although, global sales of OTC pediatric medicines through hospital pharmacies is projected to create an incremental opportunity of over US$ 300 million during 2017-2022.
Ask Industry Experts about this Report - https://www.factmr.com/connectus/sample?flag=AE&rep_id=257
Competition Tracking
The report also profiles companies that are expected to remain active in the expansion of global OTC pediatric healthcare market through 2022, which include Procter & Gamble, Johnson & Johnson, GlaxoSmithKline Plc, Abbott Laboratories, Amway Corporation, Bayer Aktiengesellschaft, Sanofi, Pfizer, Inc., Reckitt Benckiser Group plc, and Church & Dwight Co., Inc.

Comments

Popular posts from this blog

Electrosurgery Devices Market: Radiofrequency Electrosurgery Devices will Remain the Top-Selling Product

On the back of rising ageing population, increased instances of surgical procedures and technological innovations, the market for electrosurgical devices is likely to slate lucrative growth triggers in the coming years. Significant spike in surgical procedures pertaining neurology, cardiology, gynecology, and several other general surgeries, electrosurgery devices market is in the cusp of exponential growth. Owing to technological innovations the electrosurgery market in North America has demonstrated growth traction over the years. However, increased healthcare spending towards minimally invasive treatment in Asia-Pacific region is expected to propel the market forward, thus contributing as one of the fastest regional hub in electrosurgery devices market. However, factors such as significant product recalls owing to incompliance with FDA framework remain potential challenges for the growth trajectory. Get sample of this report at https://www.factmr.com/connectus/sample?flag=S...

North America to Maintain its Leader Status for the Dermatology Devices Market

 Increasing geriatric population across the world have propelled the demand for the dermatology devices, which in turn has contributed to the growth of the dermatology devices market. Rising adoption of dermatology devices in parallel to the rapid adoption of technology in the dermatology clinics and hospitals for treating skin disorders have been prominent factors for the growth of dermatology devices market. Spur in the spending capability of consumers have facilitated the access to these devices. Pervasiveness of skin disorders has been rising at the global level, which has created demand for acute treatment devices. Developments in the treatment methodologies such as liposuction devices and laser instruments have been successful in attracting the attention of the consumers. A recent report published by Fact.MR states that the global dermatology devices market is anticipated to surpass the whopping value of US$ 1,000 Mn by 2022. Browse Full Report with TOC 'https://www.factm...

Lithotripsy Devices Market: Non-Invasive ESWL Witnessing Immense Traction

The report offers a crisp overview of the lithotripsy devices market, which includes an introduction to the lithotripsy devices market in tandem with a definition of the target product – lithotripsy devices. A systematic breakdown of the lithotripsy devices market has been offered in this chapter, which implies scope of the research involved. Size of lithotripsy devices market has been studied in terms of volume (tons) and value (MN), and forecast on the lithotripsy devices market has been offered for the period between 2018 and 2026. The lithotripsy devices market is projected to continue its steady growth due to the burgeoning cases of kidney stones, coupled with the surging demand for minimally invasive medical treatments. According to Fact.MR report, the  lithotripsy devices market  is anticipated to accelerate at 4.3% CAGR during 2018-2026 to reach a value of US$ 1,095.2 MN by the end of 2026. In recent past, lithotripsy has become the most pref...